Neutralizing Antibody Responses and Evolution of the Viral Envelope in the Course of HIV-1 Korean Clade B Infection

Osong Public Health and Research Perspectives

Volumn 2, Issue 3, 2011, Pages 151-157

  Shin, Bo Gyeong ^a   Yun, Mi Ran ^a   Kim, Sung Soon ^a   Kim, Gab Jung ^a  

^a Korea National Institute of Health   (South Korea)

Author keywords

Env; HIV 1 Korean clade B; Immune escape; Longitudinal study; Neutralizing antibody

Indexed keywords

AMINO ACID; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; NEUTRALIZING ANTIBODY;

ADULT; ANIMAL CELL; ANTIBODY RESPONSE; ARTICLE; CLADISTICS; CONTROLLED STUDY; DISEASE COURSE; ENVELOPE GENE; FEMALE; GLYCOSYLATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMORAL IMMUNITY; MICROBIAL ACTIVITY; MOLECULAR EVOLUTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN TERTIARY STRUCTURE; SOUTH KOREA; VIRUS CELL INTERACTION; VIRUS ENVELOPE; VIRUS NEUTRALIZATION;

EID: 84855187038     PISSN: 22109099     EISSN: 22109110     Source Type: Journal    
DOI: 10.1016/j.phrp.2011.11.038     Document Type: Article

References (13)

1. Wei X., Decker J.M., Wang S., et al. Antibody neutralization and escape by HIV-1. Nature 2003 Mar 20, 422(6929):307-312.
2. Rambaut A., Posada D., Crandall K.A., Holmes E.C. The causes and consequences of HIV evolution. Nat Rev Genet 2004 Jan 5, 52-61.
3. Nyambi P., Burda S., Urbanski M., et al. Neutralization patterns and evolution of sequential HIV type 1 envelope sequences in HIV type 1 subtype B-infected drug-naïve individuals. AIDS Res Hum Retroviruses 2008 Dec, 24(12):1507-1519.
4. Bunnik E.M., Pisas L., van Nuenen A.C., Schuitemaker H. Autologous neutralizing humoral immunity and evolution of the viral envelope in the course of subtype B human immunodeficiency virus type 1 infection. J Virol 2008 Aug, 82(16):7932-7941.
5. Frost S.D., Wrin T., Smith D.M., et al. Neutralizing antibody responses drive the evolution of human immunodeficiency virus type 1 envelope during recent HIV infection. Proc Natl Acad Sci USA 2005 Dec 20, 102(51):18514-18519.
6. Richman D.D., Wrin T., Little S.J., Petropoulos C.J. Rapid evolution of the neutralizing antibody response to HIV type 1 infection. Proc Natl Acad Sci USA 2003 Apr, 100(7):4144-4149.
7. Kim G.J., Nam J.G., Shin B.G., et al. National survey of prevalent HIV strains: limited genetic variation of Korean HIV-1 clade B within the population of Korean men who have sex with men. J Acquir Immune Defic Syndr 2008 Jun, 48(2):127-132.
8. Shin B.G., Kim S.S., Kim G.J. Broad neutralizing antibody response and genetic variation in HIV-1 env genes in Koreans with primary HIV-1 infections. Arch Virol 2011 Mar, 153(3):465-472.
9. Li M., Gao F., Mascola J.R., et al. Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies. J Virol 2005 Aug, 79(16):10108-10125.
10. Rong R., Li B., Lynch R.M., et al. Escape from autologous neutralizing antibodies in acute/early subtype C HIV-1 infection requires multiple pathways. PLoS Pathogens 2009 Sep, 5(9):e1000594.
11. Chohan B., Lang D., Sagar M., et al. Selection for human immunodeficiency virus type 1 envelope glycosylation variants with shorter V1-V2 loop sequences occurs during transmission of certain genetic subtypes and may impact viral RNA levels. J Virol 2005 May, 79(10):6528-6531.
12. Sagar M., Wu X., Lee S., Overbaugh J. Human immunodeficiency virus type 1 V1-V2 envelope loop sequences expand and add glycosylation sites over the course of infection, and these modifications affect antibody neutralization sensitivity. J Virol 2006 Oct, 80(19):9586-9598.
13. Haldar B., Burda S., Williams C., et al. Longitudinal study of primary HIV-1 isolates in drug-naïve individuals reveals the emergence of variants sensitive to anti-HIV-1 monoclonal antibodies. PLoS One 2011 Feb 23, 6(2):e17253.